✦ LIBER ✦

Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients

✍ Scribed by J Figueras; A Bernardos; M Prieto; M Gómez; A Rimola; J Ortiz de Urbina; V Cuervas-Mons; M de la Mata; R Dominguez-Granados

Book ID: 117232220
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 55 KB
Volume: 34
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(02)02951-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two-Dose Daclizumab, Tacrolimus, Mycophe

Two-Dose Daclizumab, Tacrolimus, Mycophenolate Mofetil, and Steroid-Free Regimen in De Novo Cardiac Transplant Recipients: Early Experience

✍ S. Mastrobuoni; M. Ubilla; A. Cordero; J. Herreros; G. Rabago 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 109 KB

A prospective randomized open study in l

A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids

✍ Alejandra Otero; Evaristo Varo; Jorge Ortiz de Urbina; Rafael Martín-Vivaldi; Va 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

This open-label, randomized study compared the efficacy of a regimen of corticosteroids and tacrolimus (standard therapy group, n ϭ 79) with a regimen of daclizumab induction therapy in combination with mycophenolate mofetil and tacrolimus (modified therapy group, n ϭ 78) in primary liver transplant

Effect of daclizumab, tacrolimus, and my

Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients

✍ G Ciancio; G.W Burke; K Suzart; A Mattiazzi; A Rosen; G Zilleruello; C Abitbol; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Daclizumab induction for primary kidney

Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression

✍ G Ciancio; A Miller; G.W Burke; H Gharagozloo; A Rosen; D Roth; W Kupin; A Pinna 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Effect of daclizumab, tacrolimus and myc

Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients

✍ G Ciancio; G.W Burke; K Suzart; D Roth; W Kupin; A Rosen; C Gomez; A Mattiazzi; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Evaluation of renal function in liver tr

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial

✍ Eric M. Yoshida; Paul J. Marotta; Paul D. Greig; Norman M. Kneteman; Denis Marle 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n